• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci.

作者信息

Stamboulian D, Bonvehi P, Arevalo C, Bologna R, Cassetti I, Scilingo V, Efron E

机构信息

Department of Infectious Diseases, Sanatorio Güemes, Buenos Aires, Argentina.

出版信息

Rev Infect Dis. 1991 Jan-Feb;13 Suppl 2:S160-3. doi: 10.1093/clinids/13.supplement_2.s160.

DOI:10.1093/clinids/13.supplement_2.s160
PMID:2017645
Abstract

Thirty patients with endocarditis caused by penicillin-susceptible streptococci were enrolled in one of two groups in this study. Fifteen patients received ceftriaxone (2 g once daily) for 4 weeks; the other 15 received the same dosage of ceftriaxone for 2 weeks and then received oral amoxicillin (1 g four times a day) for 2 weeks. For the 27 patients treated predominantly as outpatients, 380 days of hospitalization were avoided. Clinical cure was achieved for all patients in both groups. We conclude that ceftriaxone, alone or followed by a course of amoxicillin, is an efficacious mode of treatment for infective endocarditis caused by penicillin-susceptible streptococci. Treatment with these agents can be administered predominantly on an outpatient basis.

摘要

相似文献

1
Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci.
Rev Infect Dis. 1991 Jan-Feb;13 Suppl 2:S160-3. doi: 10.1093/clinids/13.supplement_2.s160.
2
Treatment of endocarditis due to penicillin-susceptible streptococci with a two-week course of ceftriaxone followed by oral amoxicillin.
Eur J Clin Microbiol Infect Dis. 1992 Oct;11(10):952-3. doi: 10.1007/BF01962384.
3
Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group.头孢曲松每日一次,疗程四周,与头孢曲松加庆大霉素每日一次,疗程两周,用于治疗青霉素敏感链球菌所致的心内膜炎。心内膜炎治疗联盟组。
Clin Infect Dis. 1998 Dec;27(6):1470-4. doi: 10.1086/515038.
4
Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility.每日单次剂量头孢曲松钠治疗链球菌性心内膜炎4周。疗效及门诊治疗可行性。
JAMA. 1992 Jan 8;267(2):264-7.
5
Effect of gentamicin dosing interval on efficacy of penicillin or ceftriaxone treatment of experimental endocarditis due to penicillin-susceptible, ceftriaxone-tolerant viridans group streptococci.庆大霉素给药间隔对青霉素或头孢曲松治疗由对青霉素敏感、对头孢曲松耐受的草绿色链球菌引起的实验性心内膜炎疗效的影响。
Antimicrob Agents Chemother. 1996 Dec;40(12):2901-3. doi: 10.1128/AAC.40.12.2901.
6
Successful ceftriaxone therapy of endocarditis due to penicillin non-susceptible viridans streptococci.头孢曲松成功治疗青霉素不敏感的草绿色链球菌引起的心内膜炎。
J Infect. 2007 Feb;54(2):e99-101. doi: 10.1016/j.jinf.2006.05.010. Epub 2006 Jul 7.
7
[Possibilities and limits of outpatient antibiotic therapy of infective endocarditis].[感染性心内膜炎门诊抗生素治疗的可能性与局限性]
Herz. 2001 Sep;26(6):418-23. doi: 10.1007/pl00002045.
8
Ceftriaxone and outpatient treatment of infective endocarditis.头孢曲松与感染性心内膜炎的门诊治疗
Infect Dis Clin North Am. 1993 Mar;7(1):97-115.
9
Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci.胃肠外给予司帕沙星与头孢曲松治疗对青霉素敏感和耐药链球菌所致实验性心内膜炎的比较。
Antimicrob Agents Chemother. 1994 Dec;38(12):2683-8. doi: 10.1128/AAC.38.12.2683.
10
Streptococcal endocarditis treated with two-week antibiotic regimen: preliminary report of a partial oral regimen.
J Med Assoc Thai. 1993 Jul;76(7):374-9.

引用本文的文献

1
Switching from intravenous to oral antibiotic therapy in the treatment of infective endocarditis: a case series and literature review of real-world data.感染性心内膜炎治疗中从静脉抗生素治疗转换为口服抗生素治疗:病例系列及真实世界数据的文献综述
JAC Antimicrob Resist. 2025 Mar 4;7(2):dlaf032. doi: 10.1093/jacamr/dlaf032. eCollection 2025 Apr.
2
Breaking the Dogma of Intravenous Treatment for Infective Endocarditis: A Systematic Review and Meta-Analysis.打破感染性心内膜炎静脉治疗的教条:一项系统评价和荟萃分析
J Clin Med. 2024 Dec 10;13(24):7518. doi: 10.3390/jcm13247518.
3
Treatment of Complicated Gram-Positive Bacteremia and Infective Endocarditis.
复杂性革兰氏阳性菌血症和感染性心内膜炎的治疗
Drugs. 2025 Feb;85(2):193-214. doi: 10.1007/s40265-024-02135-z. Epub 2024 Dec 25.
4
Endocarditis Therapy: The Move From Expert Opinion to Evidence.心内膜炎治疗:从专家意见到循证医学的转变
J Am Coll Cardiol. 2024 Dec 3;84(23):2305-2307. doi: 10.1016/j.jacc.2024.07.063.
5
Infective Endocarditis in an Intravenous Drug User Leading to Myocardial Rupture and Hemopericardium.静脉药物使用者发生感染性心内膜炎导致心肌破裂和心包积血。
Acad Forensic Pathol. 2023 Dec;13(3-4):101-109. doi: 10.1177/19253621231214442. Epub 2023 Dec 19.
6
New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended.感染性心内膜炎的新型抗菌药物及新治疗策略:需加以捍卫的武器
J Clin Med. 2023 Dec 14;12(24):7693. doi: 10.3390/jcm12247693.
7
An Unexpected Outcome of Streptococcus sanguinis Endocarditis Associated With Orthodontic Bracing in a Young Healthy Patient.一名年轻健康患者因正畸矫治器引发血链球菌性心内膜炎的意外结局
Cureus. 2023 Jun 2;15(6):e39864. doi: 10.7759/cureus.39864. eCollection 2023 Jun.
8
Heartbreaking Decisions: The Dogma and Uncertainties of Antimicrobial Therapy in Infective Endocarditis.令人心碎的抉择:感染性心内膜炎抗菌治疗的教条与不确定性
Pathogens. 2023 May 12;12(5):703. doi: 10.3390/pathogens12050703.
9
Treatment of Infective Endocarditis: A Continuing Challenge.感染性心内膜炎的治疗:一项持续的挑战。
Antibiotics (Basel). 2023 Apr 4;12(4):704. doi: 10.3390/antibiotics12040704.
10
Patient Stratification for Oral Transitional Therapy in Bacterial Endocarditis.细菌性心内膜炎口腔过渡治疗的患者分层
Clin Infect Dis. 2023 Aug 14;77(3):494-495. doi: 10.1093/cid/ciad194.